Latest posts in

Thought Leadership

Why Use NADAC-Based Pricing Over AWP
Why Use NADAC-Based Pricing Over AWP

AWP isn’t the only way to do business anymore. In this article, you’ll learn the differences between AWP & NADAC, and why Capital Rx has adopted NADAC as the new standard for drug pricing.

Read
Eliminating “Wasteful” Drugs Can Reduce Healthcare Spending
Eliminating “Wasteful” Drugs Can Reduce Healthcare Spending

Experts estimate the cost of waste in the US healthcare system may be as high as 25% of total healthcare spending. While many healthcare sectors contribute to the waste, the pharmaceutical supply chain is an area worthy of particular attention.

Read
The Consolidated Appropriations Act & Prescription Drug Data Collection (RxDC): New Rules & Regulations Equal New Responsibilities
The Consolidated Appropriations Act & Prescription Drug Data Collection (RxDC): New Rules & Regulations Equal New Responsibilities

The Consolidated Appropriations Act of 2021 (CAA) established protections for consumers related to surprise billing and transparency in healthcare. The goal of the Act is consistent with the federal government’s desire to reduce the inflation of healthcare spending by giving a clearer line of sight into a variety of opaque healthcare cost drivers, including those that have driven persistent inflation in pharmacy cost trend for plan sponsors.

Read